Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: Sulfadoxine-pyrimethamine is not working in Malawi
Abstract
EDITOR—The paper by Plowe et al entitled “Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria” might be better titled “Sustained lack of efficacy of sulfadoxine-pyrimethamine….”1 By the start of the study period five years ago, molecular genotyping showed that Plasmodium falciparum in Malawi had already acquired significant resistance to the combination.1 2 This explains the sustained lack of efficacy; …Keywords
This publication has 5 references indexed in Scilit:
- Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective studyBMJ, 2004
- A systematic overview of published antimalarial drug trialsTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- Artesunate combinations for treatment of malaria: meta-analysisThe Lancet, 2004
- Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsyThe Lancet Infectious Diseases, 2003
- High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in MalawiActa Tropica, 2003